All In Biotech

Drug Trial Radar · NCT05330325

A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

A Study Comparing the Effect and Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® as Well as Evaluating Long-term Safety of Somapacitan in a Basket Study Design in Children With Short Stature Either Born Small for Gestational Age or With Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature

Last checked: Nov 20, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 412 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

412

Actual

Start

Aug 10, 2022

Primary completion

Aug 5, 2024

Study completion Oct 29, 2027

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Apr 15, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 10 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study compares two medicines for treatment of children born small and who stay small, or with Turner Syndrome, Noonan Syndrome, or idiopathic short stature. The purpose of the study is to see how well treatment with somapacitan works compared to treatment with Norditropin®. Somapacitan is a new medicine, and Norditropin® is a medicine doctors can already prescribe in some countries. The study will last for upto 5.5 years. The participants will either get somapacitan once a week up to 5.5 years or Norditropin® once a day for 1 year followed by somapacitan once a week for up to 4.5 years. Which treatment the participants get is decided by chance.

Conditions

  • SGA, Turner Syndrome, Noonan Syndrome, ISS

Interventions

  • SomapacitanDrug

    Somapacitan will be administered subcutaneously (s.c.) once weekly using PDS290 pen-injector.

  • Norditropin®Drug

    Norditropin® will be administered s.c. once daily using FlexPro® pen-injector.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Height velocity reported separately for small for gestational age (SGA), Turner syndrome (TS), Noonan syndrome (NS) and idiopathic short stature (ISS)Time frame: From baseline (week 0) to visit 7 (week 52)

Locations

199 sites in 33 countries. Site status is shown where the registry gives one.

  • Univ of AL at Birmingham_BRM

    Birmingham, Alabama

  • Children's Hospital Los Angeles - Endocrinology

    Los Angeles, California

  • Sutter Valley Med Fdt Ped Endo

    Sacramento, California

  • Rady Childrens Hosp San Diego

    San Diego, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Rocky Mt Ped and Endo

    Centennial, Colorado

  • Ped Endo Assoc PC-G.V

    Greenwood Village, Colorado

  • Nemours/AI duPont Hosp-Chld

    Wilmington, Delaware

  • Childrens National Medical Ctr

    Washington D.C., District of Columbia

  • Nemours Chld Clnc Jacksonville

    Jacksonville, Florida

  • Atlanta Diabetes Associates

    Atlanta, Georgia

  • St. Luke's Children's Endo

    Boise, Idaho

  • Rocky Mt Clin Res, LLC

    Idaho Falls, Idaho

  • Riley Hosp for Child-Indiana U

    Indianapolis, Indiana

  • University OF Iowa

    Iowa City, Iowa

  • UMass Medical School

    Worcester, Massachusetts

  • Univ of Minnesota M.C.H.

    Minneapolis, Minnesota

  • Children's Minnesota

    Saint Paul, Minnesota

  • Univ of Mississippi Med Ctr

    Jackson, Mississippi

  • The Children's Mercy Hospital

    Kansas City, Missouri

  • Goryeb Children's Hospital

    Morristown, New Jersey

  • UBMD Peds-Div of Endo/Diabetes

    Buffalo, New York

  • NYU Langone Hospital-LI

    Garden City, New York

  • NYU Langone Hospital-LI

    Mineola, New York

  • WakeMed Childn Endo-Dbt_Raleig

    Raleigh, North Carolina

  • Akron Children's Hospital

    Akron, Ohio

  • CCHMC_Cinc

    Cincinnati, Ohio

  • Univ Oklahoma Sci Ctr OK City

    Oklahoma City, Oklahoma

  • UPMC Child Hosp-Pittsburgh

    Pittsburgh, Pennsylvania

  • UT Southwestern Med Cntr

    Dallas, Texas

  • Cook Children's Medical Center

    Fort Worth, Texas

  • Consano Clinical Research, LLC

    Shavano Park, Texas

  • University Of Virginia Hospital

    Charlottesville, Virginia

  • MultiCare Inst for Res & Innov

    Tacoma, Washington

  • Marshfield Clinic

    Marshfield, Wisconsin

  • Krankenhaus der Stadt Dornbirn

    Dornbirn, Austria

  • LKH St. Poelten, Kinder-und Jugendheilkunde

    Sankt Pölten, Austria

  • Salzkammergut-Klinikum Vöcklabruck

    Vöcklabruck, Austria

  • Kepler Universitätsklinikum GmbH - Med Campus IV (vorm.LFKK)

    Linz, Upper Austria, Austria

  • UZ Brussel

    Brussels, Belgium

Showing 40 of 199 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.